Quantcast
NFL Trauma-Related Cognitive Issues Likely To Affect

NFL: Trauma-Related Cognitive Issues Likely To Affect One-Fourth Of All Players

Chuck Bednar for redOrbit.com - Your Universe Online Documents filed by lawyers representing the National Football League (NFL) acknowledge that at least one-fourth of players are likely to wind up suffering from dementia, Alzheimer's disease,...

Latest Alzheimer's disease Stories

2014-09-18 08:29:48

- Dr. Altstiel brings over 30 years of expertise in neurodegenerative diseases - NEWARK, N.J., Sept. 18, 2014 /PRNewswire/ -- Neurotrope, Inc. (OTCQB: NTRP) today announced the appointment of Larry D. Altstiel, M.D., Ph.D. to the Company's Board of Directors, effective September 12, 2014. The appointment of Dr. Altstiel fills a vacancy on the Board of seven members. Dr. Altstiel will also become Chairman of the Nominating and Corporate Governance Committee and a member of the Audit...

2014-09-17 23:16:06

‘Alzheimer’s—What They Forget to Tell You’ is an inspiring true account of author Caron Leid taking care of her mother for 13 years ONTARIO, Canada (PRWEB) September 17, 2014 Although more and more people are being affected by Alzheimer’s disease, there is not enough information surrounding the true daily struggle of the disease. But one thing is for sure, this disease does not only rob a person of their memory, it takes their dignity and independence with it....

2014-09-17 12:27:05

New multi-year grant furthers non-profit organization's work to accelerate the drug development process TUCSON, Ariz., Sept. 17, 2014 /PRNewswire-USNewswire/ -- The Critical Path Institute (C-Path) announced today that the U.S. Food and Drug Administration (FDA) has awarded the organization $2.1 million in first year funding of a five-year grant with the potential of $10.5 million over the five years. This is the second five-year grant that C-Path has received from the FDA under the...

2014-09-16 23:05:58

Detection, at the Icahn School of Medicine at Mount Sinai, while the patient is still alive improves accuracy of diagnosis and enables estimation of prevalence and risk. New York, NY (PRWEB) September 16, 2014 An experimental positron emission tomography (PET) tracer is effective in diagnosing concussion-related brain disease while a person is still alive, according to a case study conducted at the Icahn School of Medicine at Mount Sinai, and at Molecular Neuroimaging (MNI) LLC in New...

2014-09-16 12:31:21

DementiaWise Seminar to Provide Valuable Tips to Families with Loved Ones Suffering From Dementia CHERRY HILL, N.J., Sept. 16, 2014 /PRNewswire/ -- According to the Alzheimer's Association, by the time 1 in 3 seniors pass away, they will have been afflicted with Alzheimer's disease or another form of dementia. Dementia, a term used to describe a number of cognitive diseases which impair mental functions, can be debilitating for sufferers and heartbreaking for their loved ones. On...

2014-09-16 08:29:21

INDIANAPOLIS, Sept. 16, 2014 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and AstraZeneca today announced an agreement to co-develop and commercialize AZD3293, an oral beta secretase cleaving enzyme (BACE) inhibitor currently in development as a potential treatment for Alzheimer's disease. The progression of Alzheimer's disease is characterized by the accumulation of amyloid plaque in the brain. BACE is an enzyme associated with the development of beta-amyloid. Inhibiting BACE...

2014-09-15 08:29:32

- Significantly Improved Agitation in 220-Patient 10-week Study - ALISO VIEJO, Calif., Sept. 15, 2014 /PRNewswire/ -- Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) today announced positive results from its phase II clinical trial evaluating the safety and efficacy of AVP-923 for the treatment of agitation in patients with Alzheimer's disease. Treatment with AVP-923 was associated with significantly reduced agitation as measured by the primary endpoint, the agitation/aggression...

2014-09-11 23:12:56

A promising first-in-class drug that stimulates the creation of new nerve cells in the brains of "Alzheimer's mice," will soon be tested in the brains of human patients with the promise it can help people in the early stages of the disease, based on research funded by the Cure Alzheimer's Fund. Boston, MA (PRWEB) September 11, 2014 A promising first-in-class drug that stimulates the creation of new nerve cells in the brains of "Alzheimer's mice," will soon...

2014-09-11 12:26:44

Leading researchers and industry experts discuss how to accelerate the development of new treatments and technologies to improve the lives of people with dementia and their families and caregivers OTTAWA, Sept. 11, 2014 /CNW Telbec/ - The Honourable Rona Ambrose, Canada's Minister of Health, and Mr. Philippe Zeller, Ambassador of France to Canada, today welcomed leading dementia researchers and industry experts from G7 countries to Ottawa for the Canada-France Global Dementia Legacy Event....

2014-09-10 23:09:26

Alzheimer Society of Ontario excited to participate in novel assistive-technology effort Toronto (ON) September 10, 2014 (PRWEB) September 10, 2014 The Alzheimer Society of Ontario is excited to be part of a novel effort to develop assistive technology for people with dementia. From 12-14 September, technological innovators will convene at the Toronto dementia hackathon to tackle the most pressing challenges faced by caregivers and people with dementia, and invent… on the spot…...


Word of the Day
omadhaun
  • A fool; a simpleton: a term of abuse common in Ireland and to a less extent in the Gaelic-speaking parts of Scotland.
This word is partly Irish in origin.